Photocure Reports Q3 Adjusted EBITDA of NOK 18.5 Million
Story updates
07:31:38 AM UTC
SquawkNews
OSLO, Norway, Oct. 28, 2026 // -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 134.2 million in the third quarter of 2026 (Q3 2025: NOK 134.1 million), and Adjusted EBITDA of NOK 18.5 million (Q3 2025: NOK 18.9 million). In 2026, Photocure now expects product r…
07:32:11 AM UTC
SquawkNews
Photocure reported Q3 2026 Hexvix/Cysview revenue of NOK 134.2M (Q3 2025: NOK 134.1M) and adjusted EBITDA of NOK 18.5M (NOK 18.9M). It raised 2026 product revenue growth guidance to 10—12% cc from 8—11%.Material DetailsContext by AI AnalystThis is a mid-cycle update: sales stable, but management nu…